Flu & COVID Together: Shots & Boosters

In the midst of evolving health challenges, ensuring comprehensive protection against respiratory illnesses like COVID-19 and the flu has become more critical than ever. Pfizer’s innovative approach to developing a combined COVID-19 and Influenza mRNA Vaccine offers a promising solution. At DFW Clinical Research, we’re dedicated to exploring groundbreaking vaccination strategies that can optimize immunity against these prevalent viruses.

The synergy of getting both the COVID booster and flu shot together presents numerous advantages. This Phase 3 study focuses on assessing the safety, tolerability, and immunogenicity of a unified modified RNA (modRNA) vaccine for COVID-19 and influenza. Combining the COVID and flu shots together streamlines the vaccination process, potentially boosting overall vaccination rates. With the World Health Organization (WHO) recommending changes to the influenza vaccine composition for the 2023-2024 season, this study remains adaptable, evaluating various influenza vaccine formulations alongside the Pfizer-BioNTech COVID-19 vaccine (BNT162b2).

An article from the CDC emphasizes the importance and safety of co-administering flu and COVID-19 vaccines. It highlights that getting both vaccines at the same time is safe and effective, emphasizing the urgency due to the potential co-circulation of flu and COVID-19 viruses. The article stresses that getting vaccinated against both viruses reduces the risk of severe illness, hospitalization, and death. It encourages healthcare providers to offer and administer both vaccines simultaneously, following the established vaccine schedules and recommendations. Additionally, it reassures the public that co-administration does not affect vaccine efficacy or safety and is critical for individual and public health protection. A further article discusses the safety and benefits of receiving multiple vaccines, particularly the flu vaccine and COVID-19 vaccine, simultaneously. It addresses the importance of staying up-to-date with vaccinations and highlights that receiving both vaccines together is safe and effective. The article emphasizes that co-administration of vaccines does not impact the efficacy or safety of either vaccine. It encourages individuals to consult healthcare providers about getting vaccinated against both flu and COVID-19 and emphasizes the role of healthcare providers in offering and administering vaccines following established guidelines. Additionally, it mentions the significance of reducing the risk of severe illness and hospitalization by getting vaccinated against these respiratory viruses. Coad ministration is always an option when it comes to vaccines, but this clinical trial for a combined COVID and flu shot would cut down on some of the hassle of having to get two separate vaccines at the same time.

The prior studies (C5261001) indicated encouraging outcomes with mild to moderate side effects and robust immune responses when combining modRNA encoding influenza strains and BNT162b2. Building on these results, Phase 3 aims to evaluate selected modRNA vaccine dosages and strains in healthy adults aged 18-64. The study will compare the safety and effectiveness of this modRNA vaccine to a licensed inactivated quadrivalent influenza vaccine (QIV) when administered separately from BNT162b2.

The specific modRNA vaccine dose and strain selection will rely on Phase 1 and 2 data, detailed in the investigational product manual. The study’s approach includes a total modRNA dose of 90 μg for the quadrivalent influenza vaccine and 75 μg for the trivalent influenza vaccine, both combined with BNT162b2. The trial will take three total visits over the course of 6 months, and participants will be compensated a total of $360.

As a trusted organization working in medical research, DFW Clinical Research maintains the highest standards of ethical conduct and patient care, specializing in Internal Medicine, Dermatology, Psychiatry, Cardiovascular, Immunology, Vaccines, and Phase I trials for both healthy individuals and those with disorders. Our team of highly skilled experts is committed to providing a safe, supportive, and professional environment for all participants. We are dedicated to advancing medical knowledge through groundbreaking research and improving patient care in the healthcare field. DFW Clinical Research strives to make every subject and every client feel like our only subject and client.

At DFW Clinical Research, we invite healthy individuals aged 18-64 to participate in our Flu & COVID (together) vaccine trial. By contributing to this study, you’ll play a crucial role in advancing medical research and potentially enhancing future vaccination approaches. Participants will receive a total compensation of $360 over three visits during the course of six months, making a meaningful contribution to medical science while gaining financial benefits.

Your proactive participation in medical research can pave the way for improved vaccination strategies against flu and COVID-19. Consider joining our flu and COVID together vaccine trial to contribute to cutting-edge research while maximizing your protection against these prevalent viruses.

Sign up for the Flu & COVID vaccine trial on our website https://dfwclinicalresearch.com/ongoing-studies/ and be part of groundbreaking medical advancements.

Ongoing Studies

See if you qualify for any of these clinical trials near you that pay.